You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 275 No. 9, March 6, 1996 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Editorial
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Is Triiodothyronine Administration Beneficial in Patients Undergoing Coronary Artery Bypass Surgery?

Kenneth D. Burman, MD

JAMA. 1996;275(9):723-724.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

There have been significant advances in our understanding of thyroid pathophysiology as well as in our ability to measure thyroid-stimulating hormone (TSH), total and free triiodotriiodo- (T3), and thyroxine (T4).1 The thyroid gland normally produces approximately 90 µg of T4 and 40 µg of T3 daily; all of circulating T4 is derived from direct thyroidal secretion, whereas about 85% of T3 comes from extra thyroidal conversion of T4 to T3, with only about 15% of T3 being produced by direct thyroidal secretion. Over 99% of circulating T4 and T3 are bound to serum-binding proteins, and it is only the small unbound fraction that is biologically active. Thyroxine is mainly a prohormone, and T3 is responsible for most if not all of the biological activity attributable to thyroid hormone. In many clinical situations, including systemic illness, surgery, and . . . [Full Text PDF of this Article]


Author Affiliations

From the Endocrinology Division, Washington Hospital Center, and the Endocrine Division, George Washington University Medical Center, Washington, DC.


Footnotes

Reprint requests to Chief, Endocrine Section, Washington Hospital Center, Washington, DC 20010 (Dr Burman).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1996 American Medical Association. All Rights Reserved.